Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0L0CD
|
|||
Drug Name |
Phenylpropylamine derivative 2
|
|||
Synonyms |
PMID28051882-Compound-4
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
Wisconsin Alumni Research Foundation
|
|||
Structure |
Download2D MOL |
|||
Formula |
C21H36N2O2
|
|||
Canonical SMILES |
CCCCCCCCCCCCNCCCC1=CC=C(C=C1)[N+](=O)[O-]
|
|||
InChI |
1S/C21H36N2O2/c1-2-3-4-5-6-7-8-9-10-11-18-22-19-12-13-20-14-16-21(17-15-20)23(24)25/h14-17,22H,2-13,18-19H2,1H3
|
|||
InChIKey |
HPQAMSDOLBKJBM-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Opioid receptor sigma 1 (OPRS1) | Target Info | Ligand | [1] |
Target's Patent Info | Opioid receptor sigma 1 (OPRS1) | Target's Patent Info | [1] | |
WikiPathways | miR-targeted genes in squamous cell - TarBase | |||
miR-targeted genes in lymphocytes - TarBase |
References | Top | |||
---|---|---|---|---|
REF 1 | Are sigma modulators an effective opportunity for cancer treatment A patent overview (1996-2016).Expert Opin Ther Pat. 2017 May;27(5):565-578. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.